UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Established and emerging therapeutic uses of PDE type 5 inhibitors in cardiovascular disease

British journal of pharmacology, 2020-12, Vol.177 (24), p.5467-5488

2020

Volltextzugriff (PDF)

Advances in Therapies and Imaging for Systemic Vasculitis

Arteriosclerosis, thrombosis, and vascular biology, 2019-08, Vol.39 (8), p.1520-1541

2019

Volltextzugriff (PDF)

Choroidal and retinal thinning in chronic kidney disease independently associate with eGFR decline and are modifiable with treatment

Nature communications, 2023, Vol.14 (1), p.7720-7720, Article 7720

2023

Volltextzugriff (PDF)

The eye, the kidney, and cardiovascular disease: old concepts, better tools, and new horizons

Kidney international, 2020-08, Vol.98 (2), p.323-342

2020

Volltextzugriff (PDF)

ANCA associated vasculitis

BMJ (Online), 2020-04, Vol.369, p.m1070

2020

Volltextzugriff (PDF)

Pharmacological Effects of RAAS Blockade in Ischemic Nephropathy

Current drug metabolism, 2016-01, Vol.17 (6), p.550-558

2016

Volltextzugriff (PDF)

Antineutrophil cytoplasm antibody positivity, kidney impairment, and cholesterol embolization

Kidney international, 2021-03, Vol.99 (3), p.774-774

2021

Volltextzugriff (PDF)

Circulating argonaute-bound microRNA-126 reports vascular dysfunction and treatment response in acute and chronic kidney disease

iScience, 2021-01, Vol.24 (1), p.101937, Article 101937

2021

Volltextzugriff (PDF)

Regular Acetaminophen Use and Blood Pressure in People With Hypertension: The PATH-BP Trial

Circulation (New York, N.Y.), 2022-02, Vol.145 (6), p.416-423

2022

Volltextzugriff (PDF)

Long-term outcomes in elderly patients with ANCA-associated vasculitis

Rheumatology (Oxford, England), 2020-05, Vol.59 (5), p.1076-1083

2020

Volltextzugriff (PDF)

Arterial stiffness, endothelial dysfunction and impaired fibrinolysis are pathogenic mechanisms contributing to cardiovascular risk in ANCA-associated vasculitis

Kidney international, 2022-11, Vol.102 (5), p.1115-1126

2022

Volltextzugriff (PDF)

Retinal fingerprints for precision profiling of cardiovascular risk

Nature reviews cardiology, 2019-07, Vol.16 (7), p.379-381

2019

Volltextzugriff (PDF)

Corrigendum to “Novel retinal vascular phenotypes for the potential assessment of long-term risk in living kidney donors.” Kidney Int. 2022;102:661–665

Kidney international, 2023-02, Vol.103 (2), p.429-430

2023

Volltextzugriff (PDF)

Novel retinal vascular phenotypes for the potential assessment of long-term risk in living kidney donors

Kidney international, 2022-09, Vol.102 (3), p.661-665

2022

Volltextzugriff (PDF)

Endothelin Receptor Antagonism Improves Lipid Profiles and Lowers PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) in Patients With Chronic Kidney Disease

Hypertension (Dallas, Tex. 1979), 2019-08, Vol.74 (2), p.323-330

2019

Volltextzugriff (PDF)

Utility of interval kidney biopsy in ANCA-associated vasculitis

Rheumatology (Oxford, England), 2022-05, Vol.61 (5), p.1966-1974

2022

Volltextzugriff (PDF)

Glucocorticoid-free treatment of severe ANCA-associated vasculitis

Nephrology, dialysis, transplantation, 2021-03, Vol.36 (4), p.739-742

2021

Volltextzugriff (PDF)

Endothelin blockade prevents the long-term cardiovascular and renal sequelae of acute kidney injury in mice

Science translational medicine, 2022-12, Vol.14 (675), p.eabf5074

2022

Volltextzugriff (PDF)

Deletion of the myeloid endothelin-B receptor confers long-term protection from angiotensin II-mediated kidney, eye and vessel injury

Kidney international, 2020-11, Vol.98 (5), p.1193-1209

2020

Volltextzugriff (PDF)

Resistant Hypertension in a Dialysis Patient

Hypertension (Dallas, Tex. 1979), 2020-08, Vol.76 (2), p.278-287

2020

Volltextzugriff (PDF)

Endothelin antagonism reduces circulating galectin-3 in patients with proteinuric chronic kidney disease

Kidney international, 2018-01, Vol.93 (1), p.270-270

2018

Volltextzugriff (PDF)

Symptomatic fracture risk in the renal replacement therapy population

Nephrology, dialysis, transplantation, 2017-07, Vol.32 (7), p.1211-1216

2017

Volltextzugriff (PDF)

Serial troponin measurements to monitor risk and response to endothelin A antagonism in chronic kidney disease

Nephrology, dialysis, transplantation, 2021-01, Vol.36 (2), p.375-377

2021

Volltextzugriff (PDF)

The Eye as a Non-Invasive Window to the Microcirculation in Liver Cirrhosis: A Prospective Pilot Study

Journal of clinical medicine, 2020-10, Vol.9 (10), p.3332

2020

Volltextzugriff (PDF)

First-in-Man Demonstration of Direct Endothelin-Mediated Natriuresis and Diuresis

Hypertension (Dallas, Tex. 1979), 2017-07, Vol.70 (1), p.192-200

2017

Volltextzugriff (PDF)

1 – 25 von 35

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(30)

Publikationsform

Sprache

Englisch
(35)

Erscheinungsjahr

n.n

Thema

Science & Technology
(29)
Life Sciences & Biomedicine
(27)
Humans
(19)
Female
(11)
Urology & Nephrology
(11)
Male
(9)
Cardiovascular System & Cardiology
(7)
Adult
(6)
Hypertension
(6)
Kidney Diseases
(6)
Middle Aged
(6)
Peripheral Vascular Disease
(6)
Cardiovascular Disease
(5)
Chronic Kidney Disease
(5)
Risk Assessment
(5)
Aged
(4)
Animals
(4)
Blood Pressure
(4)
Kidney
(4)
Renal Insufficiency, Chronic - Drug Therapy
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Established and emerging therapeutic uses of PDE type 5 inhibitors in cardiovascular disease

Advances in Therapies and Imaging for Systemic Vasculitis

Choroidal and retinal thinning in chronic kidney disease independently associate with eGFR decline and are modifiable with treatment

The eye, the kidney, and cardiovascular disease: old concepts, better tools, and new horizons

ANCA associated vasculitis

Pharmacological Effects of RAAS Blockade in Ischemic Nephropathy

Antineutrophil cytoplasm antibody positivity, kidney impairment, and cholesterol embolization

Circulating argonaute-bound microRNA-126 reports vascular dysfunction and treatment response in acute and chronic kidney disease

Regular Acetaminophen Use and Blood Pressure in People With Hypertension: The PATH-BP Trial

Long-term outcomes in elderly patients with ANCA-associated vasculitis

Arterial stiffness, endothelial dysfunction and impaired fibrinolysis are pathogenic mechanisms contributing to cardiovascular risk in ANCA-associated vasculitis

Retinal fingerprints for precision profiling of cardiovascular risk

Corrigendum to “Novel retinal vascular phenotypes for the potential assessment of long-term risk in living kidney donors.” Kidney Int. 2022;102:661–665

Novel retinal vascular phenotypes for the potential assessment of long-term risk in living kidney donors

Endothelin Receptor Antagonism Improves Lipid Profiles and Lowers PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) in Patients With Chronic Kidney Disease

Utility of interval kidney biopsy in ANCA-associated vasculitis

Glucocorticoid-free treatment of severe ANCA-associated vasculitis

Endothelin blockade prevents the long-term cardiovascular and renal sequelae of acute kidney injury in mice

Deletion of the myeloid endothelin-B receptor confers long-term protection from angiotensin II-mediated kidney, eye and vessel injury

Resistant Hypertension in a Dialysis Patient

Endothelin antagonism reduces circulating galectin-3 in patients with proteinuric chronic kidney disease

Symptomatic fracture risk in the renal replacement therapy population

Serial troponin measurements to monitor risk and response to endothelin A antagonism in chronic kidney disease

The Eye as a Non-Invasive Window to the Microcirculation in Liver Cirrhosis: A Prospective Pilot Study

First-in-Man Demonstration of Direct Endothelin-Mediated Natriuresis and Diuresis

Suchergebnisse filtern